University of Michigan - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

University of Michigan - Pharmaceuticals & Healthcare - Deals and Alliances Profile

University of Michigan - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
University of Michigan - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Published Sep 27, 2016
40 pages — Published Sep 27, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

University of Michigan (UM) is a research university that offers educational and research services. The university offers graduate, undergraduate and post-doctoral levels programs in various disciplines. Its graduate schools and colleges include Rackham school of graduate studies, architecture, urban planning, education, engineering, information, kinesiology, law, medicine, music, theatre, dance, natural resources, environment, nursing and pharmacy. The university offers undergraduate studies in the areas of literature, science, architecture, urban, planning, art, design, business, education nursing, pharmacy and public policy. UM is headquartered in Ann Arbor, Michigan, the US

University of Michigan - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharmaceuticals & Healthcare eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the

  
Source:
Document ID
GDPH68892D
Country
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents23
  List of Tables31
  List of Figures41
University of Michigan, Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 201642
University of Michigan, Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 201661
University of Michigan, Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 201671
University of Michigan, Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 201682
University of Michigan, Medical Devices Deals, 2010 to YTD 2016101
University of Michigan, Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 2016113
University of Michigan, Pharmaceuticals &Healthcare, Deal Details1423
  Venture Financing141
    ViewPoint Therapeutics Raises USD4 Million in Series A Financing141
    Confo Therapeutics Raises USD7.3 Million Financing152
    Millendo Therapeutics Raises USD62 Million in Series B Venture Financing172
    Akadeum Life Sciences Raises USD1 Million in Financing Round191
  Partnerships201
    AstraZeneca and MedImmune Enter into Agreement with University of Michigan and Eli Lilly202
    IFM Therapeutics to Enter into Research Agreement with University of Michigan221
    University of Michigan Enters Into Joint Venture Agreement With International Genomics Consortium231
    University Of Michigan Medical School Enters Into Research Agreement With MedImmune241
    Galectin Therapeutics Enters Into Research Agreement With University of Michigan251
    University of Michigan Medical School Forms Joint Venture With PUHSC261
  Licensing Agreements271
    Kura Oncology Amends its Licensing Agreement with University of Michigan271
    Diapin Therapeutics Enters into Licensing Agreement with University of Michigan281
    Ascentage Pharma Amends Licensing Agreement with Regents of the University of Michigan291
    Wilson Therapeutics Enters into Licensing Agreement with University of Michigan301
    Omni Sciences Enters Into Licensing Agreement With University of Michigan311
    NanoBio Enters Into Licensing Agreement With University Of Michigan321
    Medgenics Enters Into Licensing Agreement With Regents Of The University Of Michigan331
    NeoStem Enters Into Option Licensing Agreement With University of Michigan341
  Asset Transactions351
    PDL BioPharma Acquires 75% of Royalty Interest in Cerdelga from University of Michigan for USD65.6 Million352
University of Michigan - Key Competitors371
Key Employees381
Locations And Subsidiaries391
  Head Office391
  Other Locations &Subsidiaries391
Appendix401
  Methodology401
  About GlobalData401
  Contact Us401
  Disclaimer401

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "University of Michigan - Pharmaceuticals & Healthcare - Deals and Alliances Profile" Sep 27, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/University-of-Michigan-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-17179>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). University of Michigan - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sep 27, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/University-of-Michigan-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-17179>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research